Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

481
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
481
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

913
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
913
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

393
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
393
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

271
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
271
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

827
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
827
Infection01:20

Infection

12.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
12.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same author

Tumor-infiltrating CD8<sup>+</sup>Ki-67<sup>+</sup> and CD8<sup>+</sup>LAG-3<sup>+</sup> T cells are associated with improved patient survival in retroperitoneal dedifferentiated liposarcomas and leiomyosarcomas.

Experimental and molecular pathology·2026
Same author

A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus.

Journal of translational autoimmunity·2026
Same author

Type I interferon signaling in microglia drives synaptic engulfment and neuronal loss following traumatic brain injury.

Research square·2026
Same author

Monocytes from patients with chronic non-bacterial osteomyelitis (CNO) exhibit increased 'classically activated' phenotypes and altered DNA methylation patterns.

Clinical immunology (Orlando, Fla.)·2026
Same author

Reply.

ACR open rheumatology·2026

Related Experiment Video

Updated: Feb 19, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
04:37

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections

Published on: February 2, 2024

1.3K

Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment.

Sigrun R Hofmann1, Franz Kapplusch1, Hermann J Girschick2

  • 1Pediatric Rheumatology and Immunology, Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Current Osteoporosis Reports
|October 29, 2017
PubMed
Summary

Chronic non-bacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) are autoinflammatory bone disorders. Research suggests immune cell signaling defects cause imbalanced cytokine expression, offering potential biomarkers and therapeutic targets.

Keywords:
BiomarkersBoneCNOCRMOChronic non-bacterial osteomyelitisChronic recurrent multifocal osteomyelitisCytokineInflammationTreatment

More Related Videos

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
09:09

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection

Published on: March 14, 2019

9.4K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.2K

Related Experiment Videos

Last Updated: Feb 19, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
04:37

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections

Published on: February 2, 2024

1.3K
Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
09:09

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection

Published on: March 14, 2019

9.4K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.2K

Area of Science:

  • Immunology
  • Rheumatology
  • Genetics

Background:

  • Chronic non-bacterial osteomyelitis (CNO) and its severe form, chronic recurrent multifocal osteomyelitis (CRMO), are autoinflammatory bone diseases.
  • These conditions are characterized by recurrent bone inflammation without evidence of infection.

Purpose of the Study:

  • To review the clinical presentation, diagnosis, pathophysiology, and treatment of CNO/CRMO.
  • To highlight recent advances in understanding the molecular mechanisms underlying CNO/CRMO.

Main Methods:

  • Review of existing literature on CNO/CRMO.
  • Analysis of novel data on cytokine and chemokine expression in patient monocytes and tissues.

Main Results:

  • The pathophysiology of CNO/CRMO likely involves defects in the TLR4/MAPK/inflammasome signaling pathway.
  • Imbalanced pro- and anti-inflammatory cytokine expression in monocytes is a key feature.
  • Previously unpublished data on cytokine and chemokine profiles are presented.

Conclusions:

  • CNO/CRMO is an autoinflammatory bone disorder driven by dysregulated innate immune responses.
  • Identifying specific molecular defects and signaling pathways may lead to novel biomarkers and therapeutic strategies.
  • Further research into cytokine dysregulation offers promising avenues for CNO/CRMO treatment.